These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1617688)

  • 1. Synthesis and antitumour activity of sulfoalkyl derivatives of curdlan and lichenan.
    Demleitner S; Kraus J; Franz G
    Carbohydr Res; 1992 Mar; 226(2):247-52. PubMed ID: 1617688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumour activity of derivatives of curdlan and lichenan branched at C-6.
    Demleitner S; Kraus J; Franz G
    Carbohydr Res; 1992 Mar; 226(2):239-46. PubMed ID: 1617687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities of (1-->3)-beta-D-glucans with reducing glucose side chains.
    Kiho T; Matsushita M; Usui S; Ukai S
    Biosci Biotechnol Biochem; 1998 Mar; 62(3):570-2. PubMed ID: 9571788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant activity of sulfoalkyl derivatives of curdlan.
    Lee KB; Bae JH; Kim JS; Yoo YC; Kim BS; Kwak ST; Kim YS
    Arch Pharm Res; 2001 Apr; 24(2):109-13. PubMed ID: 11339629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification, antitumor activity, and structural characterization of beta-1,3-glucan from Peziza vesiculosa.
    Mimura H; Ohno N; Suzuki I; Yadomae T
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5096-9. PubMed ID: 3830434
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance of highly branched (1-->3)-beta-D-glucans to formolysis.
    Ohno N; Terui T; Chiba N; Kurachi K; Adachi Y; Yadomae T
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1057-60. PubMed ID: 7641306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
    Ohno N; Kurachi K; Yadomae T
    J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour and immunological activity of a beta 1----3/1----6 glucan from Glomerella cingulata.
    Gomaa K; Kraus J; Rosskopf F; Röper H; Franz G
    J Cancer Res Clin Oncol; 1992; 118(2):136-40. PubMed ID: 1735734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of (1-->3)-beta-D-glucan in mice.
    Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T
    Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of cell wall beta-1,3/1,6-glucans from Phytophthora species.
    Kraus J; Blaschek W; Schütz M; Franz G
    Planta Med; 1992 Feb; 58(1):39-42. PubMed ID: 1620741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and chemical characterization of polysaccharides from Iwatake, Gyrophora esculenta Miyoshi.
    Sone Y; Isoda-Johmura M; Misaki A
    Biosci Biotechnol Biochem; 1996 Feb; 60(2):213-5. PubMed ID: 9063967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic activity of particulate yeast beta-(1-->3)-D-glucan and its water-soluble derivatives.
    Sandula J; Machová E; Hríbalová V
    Int J Biol Macromol; 1995 Dec; 17(6):323-6. PubMed ID: 8789333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural examination of antitumour, water-soluble glucans from Grifora umbellata by use of four types of glucanase.
    Miyazaki T; Oikawa N; Yamada H; Yadomae T
    Carbohydr Res; 1978 Sep; 65(2):235-43. PubMed ID: 308842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function Relationship of antitumor beta-1,3-glucan obtained from matted mycelium of cultured Grifola frondosa.
    Iino K; Ohno N; Suzuki I; Sato K; Oikawa S; Yadomae T
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):4950-6. PubMed ID: 3830423
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of grifolan on the ascites form of Sarcoma 180.
    Ohno N; Suzuki Y; Sato K; Oikawa S; Yadomae T
    Chem Pharm Bull (Tokyo); 1987 Jun; 35(6):2576-80. PubMed ID: 3664853
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of antitumor activity of grifolan by subsequent administration of (1----3)-beta-D-glucanase in vivo.
    Nono I; Ohno N; Ohsawa M; Oikawa S; Yadomae T
    J Pharmacobiodyn; 1989 Oct; 12(10):581-8. PubMed ID: 2517127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopharmacological and immunotoxicological activities of a water-soluble (1-->3)-beta-D-glucan, CSBG from Candida spp.
    Tokunaka K; Ohno N; Adachi Y; Tanaka S; Tamura H; Yadomae T
    Int J Immunopharmacol; 2000 May; 22(5):383-94. PubMed ID: 10708886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "grifolan LE" from Grifola frondosa.
    Adachi Y; Ohno N; Ohsawa M; Sato K; Oikawa S; Yadomae T
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1838-43. PubMed ID: 2805163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mass and antitumor activities of sulfated derivatives of alpha-glucan from Poria cocos mycelia.
    Lin Y; Zhang L; Chen L; Jin Y; Zeng F; Jin J; Wan B; Cheung PC
    Int J Biol Macromol; 2004 Oct; 34(5):289-94. PubMed ID: 15556230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of high-molecular-weight-(1-->3)-beta-D-glucan-dependent activation of a limulus coagulation factor G by laminaran oligosaccharides and curdlan degradation products.
    Tanaka S; Aketagawa J; Takahashi S; Shibata Y; Tsumuraya Y; Hashimoto Y
    Carbohydr Res; 1993 May; 244(1):115-27. PubMed ID: 8339297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.